ExLibris header image
SFX Logo
Title: Potential Role of Mesenchymal Stem Cells in Alleviating Intestinal Ischemia/Reperfusion Impairment
Source:

Plos One [1932-6203] yr:2013


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Wu, B. "Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion." European journal of pharmacology 705.1-3 (2013): 140-147. Link to SFX for this item
2. Zhou, G. "Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro." Inflammation (2013): 592-602. Link to SFX for this item
3. Wang, Y. "Energy metabolism disorder and myocardial injury in chronic myocardial ischemia with Qi deficiency and blood stasis syndrome based on 2-DE proteomics." Chinese Journal of Integrative Medicine 19.8 (2013): 616-620. Link to SFX for this item
4. Qiao, S. "Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-κB and upregulation of autophagy." Journal of anesthesia 27.2 (2013): 251-60. Link to SFX for this item
5. Ma J, J. "Deficiency of Capn4 gene inhibits nuclear factor-kappaB (NF-kappaB) protein signaling/inflammation and reduces remodeling after myocardial infarction." Journal of biological chemistry 287.33 (2012): 27480-9. Link to Full Text for this item Link to SFX for this item
6. MITOCARE, Study Group 4. "Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary In." Cardiology 123.4 (2012): 201-207. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced